Iron Oxide Nanoparticles Activate Innate Immunity Through Toll‐Like Receptors and Cooperate with CpG as a Potent Nano‐Adjuvant
Small · 2025
DOI: 10.1002/smll.202508378 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Chen Yang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Beijing National Laboratory for Molecular Sciences, CAS Key Laboratory of Colloid, Interface and Chemical Thermodynamics, Institute of Chemistry, Chi…. Hauptthemen laut MEDLINE: Ferric Compounds, Immunity, Innate, Metal Nanoparticles, Oligodeoxyribonucleotides. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Key R&D Program of China, Strategic Priority Research Program of the Chinese Academy of Sciences, National Natural Science Foundation of China.
Abstract (Originalsprache)
Iron oxide nanoparticles (IONPs) have wide biomedical applications and are initially considered with minimal immunogenicity. Recent studies reveal that IONPs can activate the immune system through reactive oxygen species (ROS) or interferon regulatory factor (IRF) pathways. However, the exact mechanism remains unclear. To address this question, IONP‐stemmed spherical nucleic acids (SNAs) coupled with immunostimulatory CpG strands, denoted as Fe‐CpG, are synthesized to explore the immune activation mechanisms. It is shown that Fe‐CpG efficiently entered cells and simultaneously activated TLR7, TLR8, and TLR9 within the endosome, triggering the downstream IRF5, IRF7, and NF‐κB pathways, rather than engaging in the STING pathway. The IONP core of Fe‐CpG is essential for the activation of TLR7‐ and TLR8‐mediated pathways. When used as an adjuvant with a COVID‐19 subunit vaccine, Fe‐CpG outperforms both gold nanoparticle‐based SNA and the clinically approved aluminum adjuvant. These results reveal how IONPs activate innate immune pathways and highlight the potential of Fe‐CpG as a potent nano‐adjuvant.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing National Laboratory for Molecular Sciences, CAS Key Laboratory of Colloid, Interface and Chemical Thermodynamics, Institute of Chemistry, Chinese Academy of Sciences, Beijing, 100190, China.
- University of Chinese Academy of Sciences, Beijing, 100049, China.
- Center for Molecular Imaging and Nuclear Medicine, School of Life Sciences & School for Radiological and Interdisciplinary Sciences (RAD-X) & The Second Affiliated Hospital of Soochow University, Soochow University, Suz…
ORCID-Profile: Xueguang Lu, Mingyuan Gao
Förderung
- National Key R&D Program of China
- Strategic Priority Research Program of the Chinese Academy of Sciences
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Yang, C., Meng, J., Li, W., Zhao, Y., Li, J., Wen, Y., Liu, S., Cheng, X., Mi, S., Huo, H., Lu, X., & Gao, M. (2025). Iron Oxide Nanoparticles Activate Innate Immunity Through Toll‐Like Receptors and Cooperate with CpG as a Potent Nano‐Adjuvant. Small. https://doi.org/10.1002/smll.202508378
Vancouver
Yang C, Meng J, Li W, Zhao Y, Li J, Wen Y, et al. Iron Oxide Nanoparticles Activate Innate Immunity Through Toll‐Like Receptors and Cooperate with CpG as a Potent Nano‐Adjuvant. Small. 2025. doi:10.1002/smll.202508378
BibTeX
@article{Yang2025,
author = {Yang, Chen and Meng, Junli and Li, Wei and Zhao, Yuanyuan and Li, Jingjiao and Wen, Yixing and Liu, Shuai and Cheng, Xingdi and Mi, Shiwei and Huo, Haonan and Lu, Xueguang and Gao, Mingyuan},
title = {Iron Oxide Nanoparticles Activate Innate Immunity Through Toll‐Like Receptors and Cooperate with CpG as a Potent Nano‐Adjuvant},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202508378}
}
EUVIMED